We are organized into three reporting segments. Operations that sell dispensing systems and sealing solutions primarily to the beauty, personal care and home care markets form the Beauty + Home segment. Operations that sell dispensing systems and sealing solutions to the prescription drug, consumer health care, injectables and active packaging markets form the Pharma segment. Operations that sell dispensing systems and sealing solutions to the food and beverage markets form the Food + Beverage segment.

The accounting policies of the segments are the same as those described in Note 1 – Summary of Significant Accounting Policies. In order to more closely align with how the markets analyze our segment results, we have changed our non-U.S. GAAP segment measure of profitability from Segment Income to Adjusted EBITDA beginning in 2018. All internal segment reporting and discussions of results with our Chief Operating Decision Maker (CODM) are now based on segment Adjusted EBITDA. All references to segment profitability have been updated for this change.

(1)	We evaluate performance of our reporting segments and allocate resources based upon Adjusted EBITDA. Adjusted EBITDA is defined as earnings before net interest, taxes, depreciation, amortization, unallocated corporate expenses, restructuring, acquisition-related costs and insurance recoveries.

(2)	Acquisition-related costs include transaction costs and purchase accounting adjustments related to inventory for acquisitions (see Note 20 – Acquisitions for further details).

(3)	Restructuring Initiatives includes expense items for the years ended December 31, 2019 and 2018 as follows (see Note 21 – Restructuring Initiatives for further details):


Year Ended December 31,	2019		2018		2017
Restructuring Initiatives by Segment
Beauty + Home	$	17,682	$	52,244	$	529
Pharma		632		3,589		—
Food + Beverage		391		4,185		1,679
Corporate & Other		1,767		3,811		—
Total Restructuring Initiatives	$	20,472	$	63,829	$	2,208

(4)	The gain on insurance recovery relates to the Annecy fire (see Note 19 – Insurance Settlement Receivable for further details).

(5)	Depreciation and amortization includes amortization related to acquisition purchase accounting adjustments for backlog. See the reconciliation of Non-U.S. GAAP measures starting on page 22.

(6)

The transfer of corporate technology expenditures represents amounts of projects managed by corporate for the benefit of specific entities within each segment. Once the projects are complete, all related costs are allocated from corporate to and paid by the appropriate entity and the associated assets are then depreciated at the entity level.

Geographic Information

The following are net sales and long-lived asset information by geographic area and product information for the years ended December 31, 2019, 2018 and 2017:


	2019		2018		2017
Net Sales to Unaffiliated Customers (1):
United States	$	836,768	$	726,336	$	642,164
Europe:
France		895,110		862,364		744,856
Germany		452,409		474,369		416,802
Italy		141,867		144,044		131,523
Other Europe		149,083		146,701		132,992
Total Europe		1,638,469		1,627,478		1,426,173
Other Foreign Countries		384,495		410,947		400,946
Total	$	2,859,732	$	2,764,761	$	2,469,283
Property, Plant and Equipment
United States	$	300,820	$	265,004	$	182,434
Europe:
France		338,288		308,250		266,804
Germany		163,782		154,505		163,948
Italy		53,562		54,978		57,080
Other Europe		63,636		59,411		59,963
Total Europe		619,268		577,144		547,795
Other Foreign Countries		167,590		149,465		137,677
Total	$	1,087,678	$	991,613	$	867,906

(1)	Sales are attributed to countries based upon where the sales invoice to unaffiliated customers is generated.

No single customer represents 6% or more of our net sales in 2019, 2018 or 2017.